written on 05.03.2014

Sanofi widens marketing team for slow starter Kynamro

TAGS: ,

Sales of Sanofi's rare-disease treatment Kynamro, approved last January, got off to a slow start, but that situation shouldn't persist now that the French drugmaker's Genzyme unit has beefed up its sales force.